The Next Generation of Medical Vision.
The Future of Non-Invasive Diagnostics.
MEDIR™ by INTUON is going to be a revolutionary medical diagnostic system which provides early, safe, and precise insights into your health. Using an AI-driven fusion of multi-spectral imaging (Visible, NIR, SWIR, and advanced LWIR), MEDIR™ will create a comprehensive, non-invasive map of the body's physiological and metabolic activity. It will be radiation-free, contact-free, and built to detect diseases like breast cancer earlier than ever before.
The "Why"
The Urgent Need for Earlier, Safer Detection
This section explains the critical problem in healthcare that MEDIR™ addresses. Traditional screening methods face challenges in accessibility, comfort, and cost, leading to preventative deaths. Our mission is to provide a better alternative.
Breast cancer remains a global health challenge, affecting over 2.3 million women and causing 680,000 deaths each year. The single most critical factor for survival is early detection. When found in its earliest stages, the survival rate is over 90%; when found late, it drops below 30%.
Despite progress, today's screening methods have significant limitations. Many women delay or avoid screening due to the discomfort, fear of radiation, and high costs associated with traditional imaging. Conventional thermography, while promising, often lacks the required resolution and sensitivity, leading to unreliable results.
Late detection means late intervention, higher costs, and higher mortality. We believe there is a better way.
Source: World Health Organization, 2024
How It Works
Seeing the Invisible: Fusing Light and AI
Our core technology is a synthesis of advanced optics and self-learning artificial intelligence. This section allows you to explore our two key innovation pillars: multi-spectrum imaging and AI-driven analysis.
1. Multi-Spectrum Imaging
Our platform captures data from four distinct spectral ranges to build a comprehensive physiological map:
- VIS-NIR-SWIR (400-1700 nm): This range reveals the optical and molecular properties of tissue. It analyzes how light is absorbed and scattered by key molecules like hemoglobin, water, and lipids. Because tumor tissue scatters light differently than healthy tissue, this allows us to see changes in blood oxygenation and metabolic activity.
- LWIR (8,000-12,000 nm): This is advanced thermal imaging. It detects the body's naturally emitted heat, allowing us to precisely map temperature gradients that reflect underlying blood flow, inflammation, and metabolic "hot spots" often associated with disease.
Interactive Demo: Light Scattering
Conceptual demo: Light penetrating healthy vs. tumor tissue.
Use Cases
A Versatile Platform for Modern Medicine
MEDIR™'s high sensitivity to microcirculation and metabolic activity makes it an ideal tool for a wide range of medical fields. Click on any application area below to see detailed use cases.
- Early detection of breast cancer by mapping microvascular anomalies and metabolic asymmetry.
- Screening for skin, thyroid, oral, and prostate tumors.
- Monitoring peripheral artery disease and venous insufficiency.
- Early warning for diabetic foot complications.
- Assessing conditions like arthritis, sinusitis, and soft tissue infections.
- Identifying muscle fatigue and inflammation.
- Monitoring injury recovery in real-time.
- Analyzing stroke perfusion asymmetry.
- Thermography for migraine assessment.
- Visualizing cardiometabolic and endocrine dysfunction for proactive healthcare.
About MEDIR™ - by INTUON
Driven by Cutting-Edge Optoelectronic Science
MEDIR™ is a deep tech R&D project of INTUON - a rapidly growing European technology company specializing in advanced photonics and infrared imaging. INTUON developed its first medical-diagnostic device in 2025, combining high-precision LWIR thermography with proprietary software for clinically stable thermal mapping. The system detects subtle thermal asymmetries associated with inflammation, early breast-cancer indicators, vascular or functional abnormalities, as well as temperature-distribution patterns correlated with organ-system functions and meridian-based diagnostic pathways commonly used in TCM. This platform forms the foundation for INTUON’s future AI-enhanced multispectral diagnostic system - MEDIR™. With nearly 15 years of experience, a modern electro-optical laboratory and a proven track records in business, INTUON is uniquely positioned to pioneer the next generation of medical vision.
Business Model
A Scalable Solution for Global Health
We offer a hybrid model to make MEDIR™ accessible to clinics, hospitals, and research partners worldwide. Explore our engagement models designed for flexibility and scalability.
Hardware Sales
Outright purchase of the MEDIR™ diagnostic devices.
SaaS
A subscription-based model for our AI-driven diagnostic software, ensuring continuous updates and support.
OEM & Licensing
Partnership opportunities for integrating INTUON's core technology into other medical systems.
Research Platform
Providing our data platform to pharmaceutical partners and researchers to accelerate clinical discovery.
Contact Us
Connect with the Future of Medical Vision
Whether you are a healthcare provider, a research institution, or a potential investor, we want to hear from you. Contact us to learn more about MEDIR™ and join our mission to make early, non-invasive diagnostics accessible to everyone.